Fulcrum Therapeutics™ to Participate in Upcoming November Investor Conferences

Rhea-AI Summary

Fulcrum Therapeutics (Nasdaq: FULC) announced management participation in key investor conferences. These include the Credit Suisse 30th Annual Virtual Healthcare Conference on November 11, 2021 at 4:20pm ET, the Stifel Virtual Healthcare Conference on November 17, 2021 at 11:20am ET, and the Piper Sandler 33rd Annual Virtual Healthcare Conference on November 30, 2021. Live audio webcasts will be accessible via the Investor Relations section of the Fulcrum website, with archived replays available for 30 days.

CAMBRIDGE, Mass., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced that management will be participating in the following upcoming investor conferences:

• Credit Suisse 30^th Annual Virtual Healthcare Conference
  Thursday, November 11, 2021 at 4:20pm ET

• Stifel Virtual Healthcare Conference
  Wednesday, November 17, 2021 at 11:20am ET

• Piper Sandler 33^rd Annual Virtual Healthcare Conference
  Tuesday, November 30, 2021. Webcast available beginning Monday, November 22, 2021 at 10:00am ET

Live audio webcasts will be available through the Investor Relations section of the Fulcrum website at https://ir.fulcrumtx.com/events-and-presentations. Archived replays will be available on the Company’s website for 30 days.

About Fulcrum Therapeutics

Fulcrum Therapeutics is a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases in areas of high unmet medical need. Fulcrum’s proprietary product engine, FulcrumSeek™, identifies drug targets which can modulate gene expression to treat the known root cause of gene mis-expression. Fulcrum has advanced losmapimod to Phase 2 clinical development for the treatment of facioscapulohumeral muscular dystrophy (FSHD). Fulcrum has also advanced FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and beta-thalassemia into Phase 1 clinical development.

Please visit www.fulcrumtx.com.

Contact:
Naomi Aoki
Sr. Vice President, Corporate Communications
and Investor Relations
naoki@fulcrumtx.com

FAQ

What is the date of the Credit Suisse Investor Conference for Fulcrum Therapeutics?

The Credit Suisse 30th Annual Virtual Healthcare Conference for Fulcrum Therapeutics is on November 11, 2021.

When will the Stifel Virtual Healthcare Conference occur for Fulcrum Therapeutics?

The Stifel Virtual Healthcare Conference will take place on November 17, 2021.

When can I access the Piper Sandler Virtual Healthcare Conference for Fulcrum Therapeutics?

The Piper Sandler 33rd Annual Virtual Healthcare Conference will be on November 30, 2021, with the webcast available starting November 22, 2021.

Where can I find the webcasts for Fulcrum Therapeutics' conferences?

Live audio webcasts for Fulcrum Therapeutics' conferences can be found in the Investor Relations section of their website.

What is the focus of Fulcrum Therapeutics?

Fulcrum Therapeutics specializes in developing treatments for genetically defined rare diseases with high unmet medical needs.